Uncategorized

Siemens Healthineers Atellica® VTLi Patient-Side Analyser is our product of the quarter, which Una Health will be distributing into primary care in the UK. The symptoms of myocardial infarction (MI), also known as a heart attack, can be varied and atypical so the use of testing for biomarker cardiac troponin I is crucial to transform…

Una Health was delighted to attend the fantastic fundraiser ‘An Evening With’, organised in support of The Gingerbread Centre and hosted by Bob Hall at the Valiant Suite at Port Vale FC.  Charles Hanson and David Harper from BBC Bargain Hunt were the highlight of the evening, delighting the audience with anecdotes from their times…

Una Health recently exhibited at the IBMS Congress 2022, 14th-17th of March. After many virtual events and a long interval between the last congress, we were eager to get back to the International Convention Centre in Birmingham to display and demonstrate our featured products – it’s been a long time since we’ve seen our customers…

Una Health has announced a new strategic partnership with innovation leader in medtech, Siemens Healthineers for the UK distribution of Atellica® VTLi Patient-side Immunoassay Analyser in primary care. The point-of-care device delivers proven high-sensitivity troponin I from a small sample of venous whole blood, capillary or plasma. As a recognised worldwide leader in cardiovascular disease…

Provides Lab-Quality Accuracy (97.9%), Near Patient, in 15 MinutesEuropean Launch Anticipated during Q1’22 OXFORD & CAMBRIDGE, UK and BOSTON, USA — March 8, 2022 — Global molecular diagnostics innovator, Sense Biodetection (Sense), today announced receipt of CE Marking for Veros COVID-19, the first and only fully integrated, easy-to-use molecular diagnostic test that provides laboratory-quality results…

For 2022, we decided to focus our fundraising efforts and we’re pleased to have chosen the Gingerbread Centre, who provide accommodation for homeless families, as our Charity of the Year. The Gingerbread Centre was established in Stoke-on-Trent and have been providing 24 hour supported accommodation for families across North Staffordshire since 1977. Alongside the accommodation,…

We’re delighted to announce our new partnership with Sense Biodetection. Sense is a rapidly growing global molecular diagnostic company aiming to redefine diagnostics by providing novel instrument-free rapid technology. Una Health will begin by distributing the Veros™ COVID-19 test in the UK, the first test on the Veros point-of-care molecular testing platform. The innovative self-contained…

The study that took place between June 2018 and March 2019 across 3 sites in Boston, New York and Albuquerque describes how Sight OLO has shown to be as accurate as the Sysmex XN, considered the gold standard full blood count (FBC) analyser. The American Journal of Hematology published the method comparison study which investigated…

We’re kicking off the new year by announcing TECHLAB® as our product of the quarter. TECHLAB® is a market leader of rapid, non-invasive diagnostic tests for enteric diseases to help determine whether a patient has an infection caused by Clostridioides difficile, Helicobacter pylori, protozoan parasites, or a foodborne illness. TECHLAB® also have a test range…

Last week, Carolyne Horner, Scientific Lead, Una Health Ltd attended the two-day BSAC Winter conference (9-10 December 2021). Due to the ever-changing situation associated with the COVID-19 pandemic, the meeting had been due to go ahead in person and online but was rapidly switched to a virtual meeting only. The British Society for Antimicrobial Chemotherapy…